Previous studies showed that IL-6 or IL-6 receptor antibodies can counteract, at least in part, body weight loss, fat browning and/or muscle atrophy in mouse models of cachexia [29, 44–46] with contradicting effects on tumor progression [45, 47]. The gene discussed is IL6; the disease is Cachexia.